Docetaxel and Epirubicin in Advanced Gastric Cancer

NCT00375999 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University